Thromboembolism and bleeding in systemic amyloidosis: a review,ESC Heart Failure

当前位置： X-MOL 学术 › Esc Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Thromboembolism and bleeding in systemic amyloidosis: a review
ESC Heart Failure ( IF 3.2 ) Pub Date : 2021-11-16 , DOI: 10.1002/ehf2.13701
Martin Nicol _{1,

2} , Virginie Siguret _{2,

3,

4} , Giuseppe Vergaro ₅ , Alberto Aimo ₅ , Michele Emdin ₅ , Jean Guillaume Dillinger _{1,

2} , Mathilde Baudet ₁ , Alain Cohen-Solal _{1,

2} , Camille Villesuzanne ₆ , Stephanie Harel ₆ , Bruno Royer ₆ , Bertrand Arnulf _{2,

6} , Damien Logeart _{1,

2}

Affiliation

The assessment of both thromboembolic and haemorrhagic risks and their management in systemic amyloidosis have been poorly emphasized so far. This narrative review summarizes main evidence from literature with clinical perspective.

中文翻译：